Drs. Jenkins and Stebbing join Etira Board
Dallas, TX – October 8, 2024: Etira, a clinical-stage biopharmaceutical company developing breakthrough cancer therapies, announced the appointment of Annalisa Jenkins, MBBS, FRCP and Justin Stebbing, BM, BCh, MA (oxon), FRCP FRCPath, MD, PhD to its Board of Directors. The new board members bring a strong blend of clinical, technical, and commercial experience and expertise. […]